We move beyond the traditional by delivering behavioral health and employee assistance program services; specialty health, including musculoskeletal, cardiac, advanced imaging management and physical medicine; and integrated care management to health plans, employers, Medicaid, Medicare and the Federal government.
Our full-service PBM solves complex pharmacy challenges by delivering true value-driven solutions, including total specialty drug management (distribution and engagement, formulary management and medical pharmacy) and Medicare Part D, to health plans, employers, Medicaid, Medicare, TPAs, brokers, consultants and government agencies.
Our unique vision of care
We focus on the health and well-being of every individual that we serve. We connect behavioral, physical, pharmacy and social needs into a complete picture of care that’s personalized, coordinated and cost-effective. By turning fragmented care into focused care, we empower 1 in 10 Americans to lead healthier, more vibrant lives every day.
We're hiring. Want to make a difference?
We believe in the power of people to create positive change, and are looking for hard-working, dedicated individuals who want to join a dynamic, growing company.
News about Magellan
Magellan Launches Opioid Resource Site
Magellan Health Resources was designed as a repository of research, information and materials about the opioid crisis for healthcare professionals, members of the media and researchers.
Magellan Rx Medical Pharmacy Trend Report
The industry’s only source for key trends and statistics on one of the nation’s biggest drivers of specialty spend, medical injectables. Download your copy of the Trend Report today!
The future of work is not what it used to be
Magellan CTO, Srini Koushik, shares his vision for the future of the work and shows how that future may not be so far off. In fact, it may already be here…
Magellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use Disorder
As a pioneer in the use of digital therapeutics and computerized cognitive behavioral therapy (CCBT), Magellan has engaged in a new initiative designed to measure clinical outcomes in patients with SUD by leveraging reSET®, the first ever FDA cleared prescription digital therapeutic from PEAR Therapeutics.
Magellan Selected as One of Top 100 Companies to Watch for Remote Jobs in 2018
Magellan is proud to be named in the top ten healthcare list for Top 100 Companies to Watch for Remote Jobs in 2018. We offer unparalleled, leading-edge technology that allows our associates to work remote when needed. Learn more about how your work and life can flow together in harmony at Magellan.
Groundbreaking Gene Therapy for Hemophilia
Magellan’s Haita Makanji, vice president, clinical specialty solutions, was featured in Managed Healthcare Executive this week, discussing some ground breaking new gene therapies that are available for hemophilia sufferers.